NICE’s approach to measuring value

Appleby asks whether covid-19 vaccines would be considered cost effective using the National Institute for Health and Care Excellence (NICE) approach to measuring value—and questions whether NICE’s methods are appropriate.1 The pandemic has highlighted fundamental questions about what we choose to value in society, including how to balance health impacts with wider societal and economic effects. Appleby is correct that we don’t consider the benefit and costs of vaccines at NICE. We see this momentous event as an …